Charles Schwab Investment Management Inc / ABT
Charles Schwab Investment Management Inc’s Abbott Laboratories Position
Does Charles Schwab Investment Management Inc own Abbott Laboratories (ABT)? Yes — 45.50M shares worth $4.7B (+0.71% of its 13F portfolio) as of Q1 2026, up from 13.19M shares the prior filed quarter.
Position Value
$4.7B
Q1 2026
Shares
45.50M
% of Portfolio
+0.71%
Quarters Held
30
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 45.50M | $4.7B | +0.71% |
| Q4 2025 | 13.19M | $1.7B | +0.26% |
| Q3 2025 | 13.14M | $1.8B | +0.28% |
| Q2 2025 | 13.18M | $1.8B | +0.31% |
| Q1 2025 | 13.11M | $1.7B | +0.33% |
| Q4 2024 | 12.94M | $1.5B | +0.27% |
| Q3 2024 | 12.61M | $1.4B | +0.27% |
| Q2 2024 | 12.62M | $1.3B | +0.25% |
| Q1 2024 | 12.37M | $1.4B | +0.32% |
| Q4 2023 | 12.36M | $1.3B | +0.34% |
| Q3 2023 | 12.15M | $1.2B | +0.33% |
| Q2 2023 | 12.12M | $1.3B | +0.37% |
| Q1 2023 | 12.14M | $1.2B | +0.37% |
| Q4 2022 | 12.09M | $1.3B | +0.42% |
| Q3 2022 | 11.89M | $1.2B | +0.41% |
| Q2 2022 | 11.54M | $1.3B | +0.44% |
| Q1 2022 | 11.52M | $1.4B | +0.41% |
| Q4 2021 | 11.30M | $1.6B | +0.47% |
| Q3 2021 | 11.16M | $1.3B | +0.43% |
| Q2 2021 | 11.17M | $1.3B | +0.43% |
| Q1 2021 | 10.99M | $1.3B | +0.48% |
| Q4 2020 | 10.87M | $1.2B | +0.47% |
| Q3 2020 | 10.98M | $1.2B | +0.55% |
| Q2 2020 | 11.40M | $1.0B | +0.51% |
| Q1 2020 | 11.49M | $907M | +0.53% |
| Q4 2019 | 7.80M | $677M | +0.36% |
| Q3 2019 | 7.69M | $643M | +0.38% |
| Q2 2019 | 7.65M | $644M | +0.39% |
| Q1 2019 | 7.45M | $596M | +0.38% |
| Q4 2018 | 7.18M | $519M | +0.40% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Charles Schwab Investment Management Inc’s full portfolio or all institutional holders of ABT.